Here is a study that was expected. If the vaccination campaigns of adolescents against the papillomavirus did indeed reduce the number of infections, it was not known whether this had an effect on mortality from cervical cancer.
Two epidemiologists from the prestigious Queen Mary University of London, whose study appeared in The Lancet, have just shown a notable effect of this vaccination: “In England, not a single woman aged between 20 and 24 died from cervical cancer between 2020 and 2024 [dernières données disponibles]†, explain New Scientist. Without vaccination, we would have expected 23 deaths in this age group during this period.
Human papillomavirus (HPV) infection is a very common sexually transmitted infection: it is estimated that the majority of sexually active individuals will be exposed to HPV during their lifetime. This exposure most often occurs at the very beginning of sexual life.
If for most people who encounter the virus it is eliminated by the body’s defense system, there are cases where the papillomavirus persists and exposes people to the risk of developing cancer, particularly that of the cervix. The vast majority of cervical cancers
